Class-level drug safety surveillance in hospital practice: A pharmacovigilance analysis of 84 therapeutic subclasses from a South Asian tertiary care center

Safety Actions Common With Fast-Track Cancer Drugs

Beyond the Bookshelf: Transforming Drug Information Resources through Digital Innovation

Exploring adverse events associated with vosoritide monotherapy: Insights from the FDA Adverse Event Reporting System

Cardiac disorders associated with compound long-acting bronchodilators for inhalation: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database

Are We Missing Dangerous Drug Interactions? Pharmacist-Led Telehealth Raises Red Flags in Oncology Care

Pediatric IBD: Combination Therapy Linked to Increased Skin Infection Risk

Efficacy and safety of delayed thrombolysis for ischemic stroke within 4.5–24 h: A systematic review and meta-analysis of randomized controlled trials

Inteligencia artificial en medicina: una guía ética y práctica para la asistencia sanitaria, la investigación y la docencia

Overview of counterfeiting in performance-enhancing drugs used in enhanced bodybuilding

Preliminary Quality Evaluation of New Generic Brands of Ciprofloxacin

El Invima alerta sobre la venta ilegal de cápsulas “anti-alopecia”

We need a standardized North American acetylcysteine dosing regimen for the treatment of paracetamol (acetaminophen) poisoning

Reducing delays in time-critical medications for Parkinson's disease: a multifaceted, multiprofessional quality improvement project

FDA Requests Removal of Suicidal Ideation Warning From GLP-1 RA Medications

Rethinking anti-cancer drug discovery: the evolution from polypharmacy to unified drug units

Drug-associated deep vein thrombosis: a disproportionality analysis of the FDA adverse event reporting system (FAERS) database

Exploring factors affecting access to non-communicable disease medicines in low- and middle-income countries: a systematic review

Identifying and Resolving Drug-Related Problems in Geriatric Patients

Treating Pregnant and Lactating Women: Insights from Clinical Pharmacology

Adverse Drug Events Associated with Opioid Treatment for Pain After Motor Vehicle Crash

Evaluating the impact of border management strategies on illicit trade reduction in Kenya's Ooe stop border post of Busia

Bayesian Multiple Testing for Suicide Risk in Pharmacoepidemiology: Leveraging Co-Prescription Patterns

Drug-induced intestinal obstruction: insights from the FDA Adverse Event Reporting System

THE DEADLY CONSEQUENCES OF CONTAMINATED MEDICINE: A LOOK INTO THE KILLER COUGH SYRUP CASE

HPLC Quantification and Impurity Profiling of Counterfeit Sildenafil Tablets from the African Market

Management of adverse events in TB care and active TB drug safety monitoring

Vaccine-associated lupus and related organ involvements: A pharmacovigilance analysis of VAERS database 1990–2025

Drug rash with eosinophilia and systemic symptoms: descriptive analysis of pharmacovigilance

Social media data and its potential for pharmacovigilance: a comparative analysis of reported prevalences regarding drug-induced gingival overgrowth (DIGO)

Drug-related suicidal events in children and teenagers: Age-stratified insights from FAERS

Fading microscopic codes to protect pharmaceuticals from counterfeiting

RISK FACTORS FOR POTENTIAL DRUG-DRUG INTERACTIONS OF ANALGESICS IN HOSPITALIZED UROLOGICAL PATIENTS

Safety concerns over imported counterfeit melatonin products

Amoxicillin-Clavulanate-Induced Pityriasis Rosea: A Pharmacovigilance Case Report

Boletín sobre Seguridad de Medicamentos de Uso Humano. Noviembre de 2025

El Invima advierte riesgos para la salud visual por gotas oftálmicas sin autorización de comercialización

Medication Regimen Complexity and Patient-Reported Adverse Drug Events in Korean Community Pharmacies: A Cross-Sectional Study

Vaccine Pharmacovigilance in India: Systematic Approaches and Lessons from Mass Immunization Programs

A tri-scale in silico framework integrating pharmacovigilance and mechanistic modeling suggests tepotinib-associated acute kidney injury risk